![Shou Peng Lai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 75 M $ op 31-05-2026
Shou Peng Lai has a career history that includes founding Nanjing Leads Biolabs Co., Ltd. in 2012.
Dr. Lai is the founder and holds the title of Executive Director, Chief Strategic Officer & EVP since 2015.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-06-2026 | 6.384.821 ( 4,17% ) | 50 M $ | 31-05-2026 | |
| 25-07-2025 | 3.192.410 ( 2,04% ) | 25 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NANJING LEADS BIOLABS CO., LTD. | Oprichter | 27-11-2012 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 1 |
|---|---|
Nanjing Leads Biolabs Co., Ltd.
 Nanjing Leads Biolabs Co., Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company for discovery, development and commercialization of oncology therapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
